When MIT dropouts pivot from a medical AI project to compliance automation and raise $32M Series A led by Insight Partners, you’re witnessing how the best founders identify market pain before the market even knows it exists.
What is the news?
- Karun Kaushik and Selin Kocalar-led Delve raised $32 million Series A at a $300 million valuation led by Insight Partners, with participation from Fortune 500 company CISOs, representing a 10x jump from their previous round.
- The AI compliance automation startup, founded by MIT classmates, grew from 100 customers in January to over 500 customers including AI unicorns like Lovable, Bland, and Wispr Flow.
Why is it interesting?
- As AI adoption accelerates across enterprises, compliance requirements are becoming exponentially more complex, creating massive operational bottlenecks. Delve’s AI agents automate the “alphabet soup” of compliance frameworks (HIPAA, SOC 2, PCI, GDPR, ISO) that traditionally require hundreds of manual hours, positioning them perfectly as regulatory demands intensify and companies need real-time compliance monitoring rather than periodic audits.
- The founding team’s journey from building HIPAA-compliant medical AI to automating compliance itself demonstrates exceptional market sensing. Their pivot from experiencing compliance friction firsthand to solving it for others shows how domain expertise combined with technical execution creates defensible moats. With Fortune 500 CISOs directly investing and compliance touching “every part of how a business runs,” Delve is building the infrastructure layer for the next generation of regulated AI deployments.
Read more: 21-year-old MIT dropouts raise $32M at $300M valuation led by Insight